The members' enquiry service: frequently asked questions.
de Souza
Alison
A
Clinical Effectiveness Unit, Faculty of Family Planning and Reproductive Health Care, Royal College of Obstetricians and Gynaecologists, 27 Sussex Place, Regent's Park, London NW1 4RG, UK. ffp.ceu@abdn.ac.uk
Brechin
Susan
S
Penney
Gillian
G
D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003692:Delayed-Action Preparations / Q000493:pharmacokinetics; D004347:Drug Interactions; D004789:Enzyme Activation / Q000187:drug effects; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007267:Injections / Q000592:standards; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D019338:Polypharmacy
D003271:Contraceptive Agents, Female; D003692:Delayed-Action Preparations; D003577:Cytochrome P-450 Enzyme System; D017258:Medroxyprogesterone Acetate